APO-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APO-2, covering 2024-01-31 to 2024-01-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer [Phase 1, Phase 2]